CNBX Cnbx Pharmaceuticals Inc.

Fundamentals / CIK 0001343009 / USD

Cnbx Pharmaceuticals Inc. reported $0 in revenue and a net loss of $462K for the trailing twelve months ended May 31, 2026 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.91M$953K$0-$7.08MFY 2016 Revenue: $112KFY 2016 Net Income: -$307K2016FY 2017 Revenue: $5.7KFY 2017 Net Income: -$1.93M2017FY 2018 Revenue: $9.6KFY 2018 Net Income: -$3.78M2018FY 2019 Revenue: $9.8KFY 2019 Net Income: $1.13M2019FY 2020 Revenue: $7.2KFY 2020 Net Income: -$7.47M2020FY 2021 Revenue: $0FY 2021 Net Income: -$3.19M2021FY 2022 Revenue: $30KFY 2022 Net Income: -$3.72M2022FY 2023 Revenue: $410KFY 2023 Net Income: -$3.71M2023FY 2024 Revenue: $130KFY 2024 Net Income: -$695K2024FY 2025 Revenue: $0FY 2025 Net Income: -$314K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Revenue $0 $130K $410K $30K $0 $7.2K $9.8K $9.6K $5.7K $112K
Gross Profit -- -- -- -- -- -- -- -- $5.7K $112K
Research & Development $0 $195K $432K $1.18M $1.77M $1.68M $1.54M $1.00M $247K $178K
Selling, General & Admin -- -- -- -- $849K $1.37M $1.77M $2.81M $1.61M $216K
Total Operating Expenses $272K $713K $1.34M $2.98M $2.60M $3.05M $3.31M $3.82M $1.86M $393K
Operating Income -$272K -$583K -$931K -$2.95M -$2.60M -$3.04M -$3.30M -$3.81M -$1.85M -$281K
EBITDA -$272K -$511K -$769K -$2.76M -$2.38M -$2.83M -$3.11M -$3.72M -$1.85M -$279K
Interest Expense $40K -- -- -- -- -- -- $852 $4.4K $7.2K
Net Income -$314K -$695K -$3.71M -$3.72M -$3.19M -$7.47M $1.13M -$3.78M -$1.93M -$307K
Basic EPS $0.00 -$0.02 -$0.42 -$3.59 -$2.41 -$12.05 $2.41 -$3.73 -$2.17 $0.00
Diluted EPS $0.00 -$0.02 -$0.42 -$3.59 -$2.41 -$12.05 $2.41 -$3.73 -$2.17 $0.00
Basic Shares Outstanding 90.6M 30.2M 8.8M 1.2M 1.1M 1.1M 1.1M 999.1K 916.2K 857.0K
Diluted Shares Outstanding 90.6M 30.2M 8.8M 1.2M 1.1M 1.1M 1.1M 999.1K 916.2K 857.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Cost of Revenue $0 $0 -- -- $0 $0 -- --
Gross Profit $0 $0 -- -- $0 $0 -- --
Research & Development -- $0 $0 $0 $0 $0 $0 -$74K
Total Operating Expenses $163K $73K $64K $130K $40K $65K $37K $53K
Operating Income -$163K -$73K -$64K -$130K -$40K -$65K -$37K -$53K
EBITDA -- -- -$64K -$130K -$40K -$65K -$37K -$53K
Interest Expense -- -$33K $46K $18K $14K $4.2K $3.1K --
Net Income -$154K -$44K -$114K -$150K -$60K -$70K -$34K -$61K
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 -$0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 -$0.00 --
Basic Shares Outstanding 1.32B 931.0M 732.9M -- 42.6M 32.1M 31.1M --
Diluted Shares Outstanding 1.32B 931.0M 732.9M -- 42.6M 32.1M 31.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Cash & Cash Equivalents $15K $26K $130K $118K $1.39M $778K $266K $1.39M $1.39M $19K
Short-Term Investments -- -- -- -- -- $0 $3.26M $0 -- --
Cash & Short-Term Investments $15K $26K $130K $118K $1.39M $778K $3.52M $1.39M $1.39M $19K
Total Current Assets $18K $31K $224K $198K $1.59M $930K $4.31M $1.62M $3.52M $22K
Property, Plant & Equipment, Net $0 $0 $275K $437K $643K $863K $1.00M $974K $120K $1.6K
Total Non-Current Assets $0 $0 $275K $613K $1.49M $1.29M $10.88M $1.56M $120K $1.6K
Total Assets $18K $31K $499K $811K $3.08M $2.22M $15.18M $3.18M $3.64M $24K
Short-Term Debt $0 -- -- -- -- -- -- -- -- --
Total Current Liabilities $2.51M $2.51M $2.52M $2.44M $1.27M $455K $439K $539K $699K $491K
Total Non-Current Liabilities $0 $0 $0 -- $0 $0 $0 $0 $5.88M $0
Total Liabilities $2.51M $2.51M $2.52M -- $1.27M $455K $439K $539K $6.58M $491K
Total Debt (incl. Leases) $0 -- -- -- -- -- -- -- -- --
Common Stock $55K $3.1K $2.3K $124 $14K $14K $13K $12K $12K $11K
Retained Earnings -$25.27M -$24.95M -$24.26M -$20.55M -$16.83M -$13.63M -$6.16M -$7.30M -$3.52M -$1.59M
Accumulated Other Comp. Income $0 $0 $0 -$2.57M -$1.91M -$2.77M $2.81M $0 -- --
Total Stockholders' Equity -$2.50M -$2.48M -$2.02M $1.63M $1.81M $1.76M $14.74M $2.65M -$2.94M -$467K
Total Equity -$2.50M -$2.48M -$2.02M $1.63M $1.81M $1.76M $14.74M $2.65M -$2.94M -$467K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Cash & Cash Equivalents $9.5K $12K $7.7K $15K $14K $46K $17K $26K
Cash & Short-Term Investments $9.5K $12K $7.7K $15K $14K $46K $17K $26K
Total Current Assets $13K $15K $11K $18K $19K $51K $22K $31K
Property, Plant & Equipment, Net $0 $0 $0 $0 $0 $0 $0 $0
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $13K $15K $11K $18K $19K $51K $22K $31K
Short-Term Debt $120K $75K -- $0 -- -- -- --
Total Current Liabilities $2.67M $2.55M $2.58M $2.51M $2.56M $2.62M $2.54M $2.51M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $2.67M $2.55M $2.58M $2.51M $2.56M $2.62M $2.54M $2.51M
Total Debt (incl. Leases) $120K $75K -- $0 -- -- -- --
Common Stock $148K $113K $75K $55K $9.3K $3.4K $3.1K $3.1K
Retained Earnings -$25.58M -$25.43M -$25.38M -$25.27M -$25.12M -$25.06M -$24.99M -$24.95M
Accumulated Other Comp. Income $0 $0 -- $0 -- $0 -- $0
Total Stockholders' Equity -$2.66M -$2.53M -$2.57M -$2.50M -$2.54M -$2.57M -$2.51M -$2.48M
Total Equity -$2.66M -$2.53M -$2.57M -$2.50M -$2.54M -$2.57M -$2.51M -$2.48M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Net Income -$314K -$695K -$3.71M -$3.72M -$3.19M -$7.47M $4.36M $0 -$1.93M -$307K
Depreciation & Amortization $0 $72K $162K $199K $221K $215K $189K $88K $7.0K $1.6K
Stock-Based Compensation $0 $140K $180K $729K $0 $72K $247K $1.85M $881K $30K
Operating Cash Flow -$171K -$244K -$113K -$1.68M -$2.49M -$2.77M -$3.09M -$1.97M -$864K -$120K
Investing Cash Flow $0 $113K $25K $25K $645K $3.29M -$5.25M -$1.44M -$126K $0
Common Stock Issued -- -- -- -- -- $0 $7.29M $1.55M $4.41M $94K
Financing Cash Flow $160K $28K $100K $390K $2.46M $0 $7.22M $1.44M $4.34M $114K
Net Change in Cash -$11K -$103K $12K -$1.26M $609K $512K -$1.13M -$1.97M $3.35M -$6.1K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Net Income -$154K -$44K -$114K -$150K -$60K -$70K -$34K -$61K
Depreciation & Amortization -- -- $0 $0 $0 $0 $0 $0
Stock-Based Compensation -- -- $0 $0 $0 $0 $0 $35K
Operating Cash Flow -$48K -$31K -$47K -$29K -$52K -$52K -$39K -$48K
Investing Cash Flow -- -- $0 $0 $0 $0 $0 $0
Common Stock Issued -- -- -- -- -- -- $30K --
Financing Cash Flow $45K $35K $40K $30K $20K $80K $30K $1.3K
Net Change in Cash -$2.7K $4.5K -$7.4K -- -$32K $28K -$9.1K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Gross Margin -- -- -- -- -- -- -- -- 100.0% 100.0%
Operating Margin -- -448.3% -227.1% -9860.4% -- -42524.1% -33563.0% -39670.1% -32616.1% -249.5%
Net Profit Margin -- -534.5% -904.6% -12428.2% -- -104337.9% 11510.4% -39335.7% -34022.5% -273.0%
Return on Equity (ROE) -- -- -- -228.1% -176.9% -423.2% 7.7% -142.8% -- --
Return on Assets (ROA) -1703.0% -2215.2% -743.5% -459.0% -103.8% -336.5% 7.5% -118.6% -53.2% -1295.2%
Current Ratio 0.01x 0.01x 0.09x 0.08x 1.25x 2.04x 9.81x 3.01x 5.03x 0.04x
Quick Ratio 0.01x 0.01x 0.05x 0.05x 1.09x 1.71x 8.03x 2.58x 1.99x 0.04x
Revenue Growth (YoY) -100.0% -68.3% +1269.1% -- -100.0% -27.3% +2.5% +68.9% -94.9% --
Gross Profit Growth (YoY) -- -- -- -- -- -- -- -- -94.9% --
Net Income Growth (YoY) -- -- -- -- -- -759.1% -- -- -- --
EPS Growth (YoY) -- -- -- -- -- -600.0% -- -- -- --
5Y Revenue / Share Growth -100.0% -52.0% +383.7% +294.9% -100.0% -- -- -- -- --
5Y Net Income / Share Growth -- -102.2% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Operating Margin -- -- -- -- -- -- -1102.6% -448.3%
Net Profit Margin -- -- -- -- -- -- -1356.0% -534.5%
Return on Assets (ROA) -3611.5% -2467.6% -3523.9% -1703.0% -1205.8% -583.0% -2470.1% -2215.2%
Current Ratio 0.00x 0.01x 0.00x 0.01x 0.01x 0.02x 0.01x 0.01x
Quick Ratio 0.00x 0.00x 0.00x 0.01x 0.01x 0.02x 0.01x 0.01x
Revenue Growth (YoY) -- -- -- -- -- -100.0% -100.0% -100.0%
Gross Profit Growth (YoY) -- -- -- -- -- -100.0% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -23219.6% -- -- -335.2%
Source: SEC EDGAR CompanyFacts (CIK 0001343009) · from August 31, 2005 Data through May 31, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal